Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Latex Allergy

  • Author: Amy J Behrman, MD; Chief Editor: Erik D Schraga, MD  more...
 
Updated: Jan 08, 2016
 

Background

Allergy to natural rubber latex is common and serious in children and adults. Latex is the milky fluid derived from the lactiferous cells of the rubber tree, Hevea brasiliensis. It is composed primarily of cis -1,4-polyisoprene, a benign organic polymer that confers most of the strength and elasticity of latex. It also contains a large variety of sugars, lipids, nucleic acids, and highly allergenic proteins.

More than 200 polypeptides have been isolated from latex. Latex proteins vary in their allergenic potential. Protein content varies with harvest location and manufacturing process. Basic knowledge of the manufacturing processes aids in understanding the medical problems related to latex exposure.[1]

Freshly harvested latex from Malaysia, Indonesia, Thailand, and South America is treated with ammonia and other preservatives to prevent deterioration during transport to factories. Latex is treated with antioxidants and accelerators to strengthen the product during the manufacturing process, including carbamates, mercaptobenzothiazoles, and thiurams, which have allergenic potential of their own.[2, 3] It is then shaped into the desired object and vulcanized to produce disulfide cross-linking of latex molecules.

After being dried and rinsed to reduce proteins and impurities, the product frequently is dry-lubricated with cornstarch or talc powder. Powder particles rapidly adsorb residual latex proteins; other proteins remain in soluble form on the surface of finished products.

Latex is ubiquitous in modern society and particularly in health care. William Halstead first used latex surgical gloves in 1890. Latex has been used in a myriad of medical devices for decades. In the late 1980s, however, latex glove use in healthcare skyrocketed, driven by efforts to reduce occupational exposure to blood-borne pathogens, particularly human immunodeficiency virus (HIV). Billions of pairs of medical gloves are imported to the United States annually, often as powdered, nonsterile examination gloves.

In the 1980s and 1990s, heightened demand for latex to manufacture gloves and other objects resulted in hundreds of new, poorly regulated latex factories in tropical countries. The incidence of minor and serious allergic reactions to latex began to rise rapidly among patients and health care workers (HCWs) around the world.[4, 5, 6, 7, 8] Latex sensitization can occur after skin or mucosal contact, after peritoneal contact during surgery, and after inhalation of aerosolized particles with adsorbed latex on their surfaces.

See All About Allergies: Be Ready for Spring, a Critical Images slideshow, to help identify a variety of allergens and symptoms.

For related information, see Medscape's Allergy & Immunology Resource Center.

Next

Pathophysiology

Latex exposure is associated with 3 clinical syndromes.

Irritant dermatitis results from mechanical disruption of the skin due to the rubbing of gloves and accounts for the majority of latex-induced local skin rashes. It is not immune mediated, is not associated with allergic complications, and is not the subject of this article. It may be confused with Type IV hypersensitivity. Any chronic hand dermatitis in HCWs raises the risk of nosocomial infections, including blood-borne pathogens, and should be addressed to identify and remove irritants.

The second syndrome is a delayed (type IV) hypersensitivity reaction, resulting in a typical allergic contact dermatitis. Symptoms usually develop within 24-48 hours of cutaneous or mucous membrane exposure to latex in a sensitized person. The primary allergens are residual accelerators and antioxidants left from the original manufacturing process. Langerhans cells process the antigens and present them to cutaneous T cells. Multiple objects can cause sensitization, but the most common sources in this country are probably nonsterile examination gloves for adults and shoe soles for children. Type IV hypersensitivity is more common in atopic individuals. The dermatitis may predispose patients to further sensitizations or infections.

The third, most serious, and least common syndrome is immediate (type I) hypersensitivity. It is mediated by an immunoglobulin E (IgE) response specific for latex proteins. As noted, latex proteins are highly allergenic, and they are variable between lots from different plantations, factories, and manufacturers. Cross-linking of IgE molecules on mast cell and basophil cell membranes by latex protein allergens triggers the release of histamine and other mediators of the systemic allergic cascade in sensitized individuals.[9]

Exposure can occur following skin, mucous membrane, or visceral/peritoneal contact. Powdered latex examination gloves have been the most frequent source of sensitization in adults, causing cutaneous and inhalational exposures, most often affecting the HCWs wearing them. (Fortunately, their use is decreasing as many hospitals move toward powder-free, "low-allergen," or nonlatex glove products.)[10]

It also can follow inhalation of latex-laden particles or bloodstream exposure to soluble latex proteins following intravascular access procedures.[11] Anaphylaxis during anesthesia and in the perioperative period is increasingly recognized as a manifestation of type I allergy to latex.[12, 13, 14] It can be fatal without emergent treatment.[15]

Sensitization is more common in atopic individuals. Symptoms generally begin within minutes of exposure. The spectrum of clinical manifestations includes localized or generalized urticaria, rhinitis, conjunctivitis, bronchospasm, laryngospasm, hypotension, and full-blown anaphylaxis.

Previous
Next

Epidemiology

Frequency

United States

Latex allergy is present in 1-5% of the general population, with an increased prevalence in atopic individuals. Latex allergy is increased in populations with chronic occupational exposure to latex.[16] It is found in 8-12% of HCWs[17] and in at least 10% of rubber industry workers. Symptoms of latex allergy have been described in 14% of a group of EMS providers and in 54% of a pediatric ED staff.[18, 19, 20] Atopy raises the risk of occupational sensitization.

The highest prevalence of latex allergy (20-68%) has been reported in patients with spina bifida or congenital urogenital abnormalities. Sensitization in these patients apparently follows multiple urinary tract, rectal, and thecal procedures, as well as multiple surgeries during early childhood. Children with spinal cord injuries also have increased incidence of latex allergy,[21]  although children with spinal dysraphism in one study had a low prevalence.[22] Patients with spina bifida may have a genetic predisposition for latex sensitization. Patients with spina bifida and human leukocyte antigen (HLA) alleles DRB and DQB1 were more likely to have a specific IgE response to a common latex antigen. Again, within this risk group, atopic children are at increased risk.

Other patients with a history of multiple surgeries or other latex-exposing procedures are also at increased risk relative to the general population. Patients with cerebral palsy, mental retardation, or paraplegia also appear to have increased risk of latex allergy, probably because of repeated medical exposures.

Finally, the prevalence of latex allergy is increased in persons with allergies to avocado, banana, chestnut, kiwi, papaya, peach, or nectarine. Cross-reacting antigens have been found between these tropical fruits and latex.

International

The occupational and nonoccupational risk patterns described above are similar in other developed countries, documented in an extensive international literature now focused more on interventions to reduce latex allergy in HCWs and other populations than on simply describing their increased risk.[2, 23, 24] Workers with occupational exposure during harvesting and/or processing latex in developing countries where H brasiliensis is grown have an increased risk relative to the general populations.[16, 25]

Mortality/Morbidity

Patients with type I hypersensitivity are at risk of developing anaphylaxis and/or respiratory obstruction, which can be fatal.

Deaths have been reported following the intraoperative or procedural use of latex devices. Latex anaphylaxis has occurred after childbirth, instrumentation, intravenous injection, balloon blowing, condom use, and hyperbaric treatment.[15, 12, 14, 13, 26]

Although most patients can be treated effectively for type IV and type I reactions without clinical sequelae, major allergy may prevent them from pursuing certain careers, using many household and workplace objects, and seeking timely medical care due to justified fear of latex exposure.

Sex

Incidence in males and females is equal.

Age

Latex allergy probably is more common in children and in younger working adults because of the increased medical and/or occupational exposure over the past decades.

Previous
 
 
Contributor Information and Disclosures
Author

Amy J Behrman, MD Associate Professor, Department of Emergency Medicine, Director, Division of Occupational Medicine, University of Pennsylvania School of Medicine

Amy J Behrman, MD is a member of the following medical societies: American College of Physicians, American College of Occupational and Environmental Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Matthew M Rice, MD, JD, FACEP Senior Vice President, Chief Medical Officer, Northwest Emergency Physicians of TeamHealth; Assistant Clinical Professor of Medicine, University of Washington School of Medicine Pending Approval

Matthew M Rice, MD, JD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, National Association of EMS Physicians, Society for Academic Emergency Medicine, Washington State Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Erik D Schraga, MD Staff Physician, Department of Emergency Medicine, Mills-Peninsula Emergency Medical Associates

Disclosure: Nothing to disclose.

Additional Contributors

Mark Louden, MD Assistant Professor of Clinical Medicine, Division of Emergency Medicine, Department of Medicine, University of Miami, Leonard M Miller School of Medicine

Mark Louden, MD is a member of the following medical societies: American College of Emergency Physicians

Disclosure: Nothing to disclose.

Acknowledgements

Marilyn Howarth, MD Center for Excellence in Environmental Toxicology, University of Pennsylvania

Marilyn Howarth, MD is a member of the following medical societies: American College of Occupational and Environmental Medicine

Disclosure: Nothing to disclose.

References
  1. Gawchik SM. Latex allergy. Mt Sinai J Med. 2011 Sep-Oct. 78(5):759-72. [Medline].

  2. Geier J, Lessmann H, Mahler V, Pohrt U, Uter W, Schnuch A. Occupational contact allergy caused by rubber gloves--nothing has changed. Contact Dermatitis. 2012 Sep. 67(3):149-56. [Medline].

  3. Pak VM, Watkins M, Green-McKenzie J. What is the role of thiurams in allergy to natural rubber latex products?. J Occup Environ Med. 2012 May. 54(5):649-50. [Medline].

  4. Agarwal S, Gawkrodger DJ. Latex allergy: a health care problem of epidemic proportions. Eur J Dermatol. 2002 Jul-Aug. 12(4):311-5. [Medline].

  5. Feng C, Wang H. Natural rubber latex allergy among health care workers. J Allergy Clin Immunol. 2007 Jun. 119(6):1561; author reply 1561. [Medline].

  6. Palosuo T, Antoniadou I, Gottrup F, Phillips P. Latex medical gloves: time for a reappraisal. Int Arch Allergy Immunol. 2011. 156(3):234-46. [Medline].

  7. Caballero ML, Quirce S. Identification and practical management of latex allergy in occupational settings. Expert Rev Clin Immunol. 2015 Sep. 11 (9):977-92. [Medline].

  8. Paul A, Chabaud M, Auber F, Peycelon M, Audry G. [Latex-free hospitals: Benefits and disadvantages]. Arch Pediatr. 2015 Sep 24. [Medline].

  9. Ahmed SM, Aw TC, Adisesh A. Toxicological and immunological aspects of occupational latex allergy. Toxicol Rev. 2004. 23(2):123-34. [Medline].

  10. Jackson EM, Arnette JA, Martin ML, Tahir WM, Frost-Arner L, Edlich RF. A global inventory of hospitals using powder-free gloves: a search for principled medical leadership. J Emerg Med. 2000 Feb. 18(2):241-6. [Medline].

  11. Sekiya K, Watai K, Taniguchi M, Mitsui C, Fukutomi Y, Tanimoto H. Latex anaphylaxis caused by a Swan-Ganz catheter. Intern Med. 2011. 50(4):355-7. [Medline].

  12. Bernardini R, Catania P, Caffarelli C, et al. Perioperative latex allergy. Int J Immunopathol Pharmacol. 2011 Jul-Sep. 24(3 Suppl):S55-60. [Medline].

  13. Caffarelli C, Stringari G, Miraglia Del Giudice M, Crisafulli G, Cardinale F, Peroni DG. Prevention of allergic reactions in anesthetized patients. Int J Immunopathol Pharmacol. 2011 Jul-Sep. 24(3 Suppl):S91-9. [Medline].

  14. Dong SW, Mertes PM, Petitpain N, Hasdenteufel F, Malinovsky JM,. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiol. 2012 Aug. 78(8):868-78. [Medline].

  15. Thong BY, Yeow-Chan. Anaphylaxis during surgical and interventional procedures. Ann Allergy Asthma Immunol. 2004 Jun. 92(6):619-28. [Medline].

  16. Ahmed DD, Sobczak SC, Yunginger JW. Occupational allergies caused by latex. Immunol Allergy Clin North Am. 2003 May. 23(2):205-19. [Medline].

  17. Occupational Safety and Health Administration. Latex Allergy. US Department of Labor. Available at http://www.osha.gov/SLTC/latexallergy/index.html. Accessed: June 28, 2013.

  18. Dorevitch S, Forst L. The occupational hazards of emergency physicians. Am J Emerg Med. 2000 May. 18(3):300-11. [Medline].

  19. Fein JA, Selbst SM, Pawlowski NA. Latex allergy in pediatric emergency department personnel. Pediatr Emerg Care. 1996 Feb. 12(1):6-9. [Medline].

  20. Galindo MJ, Quirce S, Garcia OL. Latex allergy in primary care providers. J Investig Allergol Clin Immunol. 2011. 21(6):459-65. [Medline].

  21. Schottler J, Vogel LC, Sturm P. Spinal cord injuries in young children: a review of children injured at 5 years of age and younger. Dev Med Child Neurol. 2012 Dec. 54(12):1138-43. [Medline].

  22. Goldberg H, Aharony S, Levy Y, Sivan B, Baniel J, Ben Meir D. Low prevalence of latex allergy in children with spinal dysraphism in non-latex-free environment. J Pediatr Urol. 2015 Sep 5. [Medline].

  23. Al-Niaimi F, Chiang YZ, Chiang YN, Williams J. Latex allergy: assessment of knowledge, appropriate use of gloves and prevention practice among hospital healthcare workers. Clin Exp Dermatol. 2013 Jan. 38(1):77-80. [Medline].

  24. Turner S, McNamee R, Agius R, Wilkinson SM, Carder M, Stocks SJ. Evaluating interventions aimed at reducing occupational exposure to latex and rubber glove allergens. Occup Environ Med. 2012 Dec. 69(12):925-31. [Medline].

  25. Liss GM, Sussman GL. Latex sensitization: occupational versus general population prevalence rates. Am J Ind Med. 1999 Feb. 35(2):196-200. [Medline].

  26. Marmo M, Sacerdoti C, Di Minno RM, Guarino I, Villani R, Di lorio C. Anaphylactic shock during hyperbaric oxygen therapy. Undersea Hyperb Med. 2012 Jan-Feb. 39(1):613-6. [Medline].

  27. Taylor JS, Erkek E. Latex allergy: diagnosis and management. Dermatol Ther. 2004. 17(4):289-301. [Medline].

  28. Hamilton RG, Peterson EL, Ownby DR. Clinical and laboratory-based methods in the diagnosis of natural rubber latex allergy. J Allergy Clin Immunol. 2002 Aug. 110(2 Suppl):S47-56. [Medline].

  29. Accetta Pedersen DJ, Klancnik M, Elms N, et al. Analysis of available diagnostic tests for latex sensitization in an at-risk population. Annals of Allergy, Asthma, & Immunology. February 2012. 108(2):94-7.

  30. Saulnier N, Nucera E, Altomonte G, Rizzi A, Pecora V, Aruanno A. Gene expression profiling of patients with latex and/or vegetable food allergy. Eur Rev Med Pharmacol Sci. 2012 Sep. 16(9):1197-210. [Medline].

  31. Blanco C, Carrillo T, Ortega N, Alvarez M, Dominguez C, Castillo R. Comparison of skin-prick test and specific serum IgE determination for the diagnosis of latex allergy. Clin Exp Allergy. 1998 Aug. 28(8):971-6. [Medline].

  32. Bernardini R, Mistrello G, Pucci N, et al. Diagnostic value of three different latex extracts. Int J Immunopathol Pharmacol. 2007 Apr-Jun. 20(2):393-400. [Medline].

  33. Food and Drug Administration. Natural rubber containing medical devices: user labeling.[Docket No. 96N-0119]. 21 CFR Part 801 Fed. Regist. 1997. 62:51021-51030.

  34. Korniewicz DM, Chookaew N, El-Masri M, Mudd K, Bollinger ME. Conversion to low-protein, powder-free surgical gloves: is it worth the cost?. AAOHN J. 2005 Sep. 53(9):388-93. [Medline].

  35. Phillips VL, Goodrich MA, Sullivan TJ. Health care worker disability due to latex allergy and asthma: a cost analysis. Am J Public Health. 1999 Jul. 89(7):1024-8. [Medline]. [Full Text].

  36. Allmers H, Brehler R, Chen Z, Raulf-Heimsoth M, Fels H, Baur X. Reduction of latex aeroallergens and latex-specific IgE antibodies in sensitized workers after removal of powdered natural rubber latex gloves in a hospital. J Allergy Clin Immunol. 1998 Nov. 102(5):841-6. [Medline].

  37. LaMontagne AD, Radi S, Elder DS, Abramson MJ, Sim M. Primary prevention of latex related sensitisation and occupational asthma: a systematic review. Occup Environ Med. 2006 May. 63(5):359-64. [Medline]. [Full Text].

  38. Filon FL, Radman G. Latex allergy: a follow up study of 1040 healthcare workers. Occup Environ Med. 2006 Feb. 63(2):121-5. [Medline]. [Full Text].

  39. Yagami A, Suzuki K, Kano H, Matsunaga K. Follow-up study of latex-allergic health care workers in Japan. Allergol Int. 2006 Sep. 55(3):321-7. [Medline].

  40. Kelly KJ, Wang ML, Klancnik M, Petsonk EL. Prevention of IgE Sensitization to Latex in Health Care Workers After Reduction of Antigen Exposures. J Occup Environ Med. 2011 Aug. 53(8):934-40. [Medline].

  41. American College of Occupational and Environmental Medicine. Anaphylaxis awareness in the workplace. 2013. Available at http://www.acoem.org/anaphylaxis.aspx. Accessed: June 28, 2013.

  42. Biagini RE, MacKenzie BA, Sammons DL, et al. Latex specific IgE: performance characteristics of the IMMULITE 2000 3gAllergy assay compared with skin testing. Ann Allergy Asthma Immunol. 2006 Aug. 97(2):196-202. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.